# CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

> **NCT03940846** · — · UNKNOWN · sponsor: **Maastricht University** · enrollment: 650 (estimated)

## Conditions studied

- Nonsmall Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Virtual biopsy

## Key facts

- **NCT ID:** NCT03940846
- **Lead sponsor:** Maastricht University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2020-10-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2020-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940846, "CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03940846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*